# Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results
Canonical URL: https://biopharmsignal.com/news/BSX/boston-scientific-announces-participation-in-bernstein-s-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results
Ticker: BSX
Company: Boston Scientific
Source: Boston Scientific
Published: 2026-05-04 12:00 EST
Original Source URL: https://news.bostonscientific.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-19 10:31 EST — [FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints](https://biopharmsignal.com/news/BSX/fracture-ide-trial-of-the-boston-scientific-seismiqtm-4ce-coronary-intravascular-lithotripsy-catheter-meets-primary-safety-and-effectiveness-endpoints) — Source: Boston Scientific
- 2026-05-18 11:00 EST — [Boston Scientific enters into $2 billion accelerated share repurchase agreement](https://biopharmsignal.com/news/BSX/boston-scientific-enters-into-2-billion-accelerated-share-repurchase-agreement) — Source: Boston Scientific
- 2026-05-18 10:30 EST — [Boston Scientific announces strategic investment in MiRus LLC](https://biopharmsignal.com/news/BSX/boston-scientific-announces-strategic-investment-in-mirus-llc) — Source: Boston Scientific
- 2026-05-04 12:00 EST — [Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results](https://biopharmsignal.com/news/BSX/boston-scientific-announces-participation-in-bernstein-s-42nd-annual-strategic-decisions-conference-and-conference-call-discussing-second-quarter-2026-results) — Source: Boston Scientific
- 2026-04-26 17:00 EST — [Data at Heart Rhythm 2026 highlight key Boston Scientific therapies](https://biopharmsignal.com/news/BSX/data-at-heart-rhythm-2026-highlight-key-boston-scientific-therapies) — Source: Boston Scientific
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)